The overexpression of the tumor suppressor mitogen-inducible gene-6 (Mig-6) abrogated the development of Pten-loss-of function-induced endometrial carcinoma [45], whereas the ablation of Mig-6 accelerated the timeline of developing endometrial carcinoma and its severity [46]. The gene discussed is PTEN; the disease is endometrial carcinoma.